Researchers from four laboratories that perform diagnostic genetic 
      testing of chromosome abnormalities in individuals with unexplained 
      physical and developmental disabilities recently identified a previously 
      unrecognized genetic disorder.
    
“In a substantial proportion of children with mental retardation and 
      developmental delays, the genetic basis is unknown”
    
      In their study, published in the American 
      Journal of Human Genetics, researchers at Signature Genomic 
      Laboratories, Nationwide Children’s Hospital, Emory University School of 
      Medicine and Baylor College of Medicine independently identified a total 
      of seven individuals with nearly identical-sized deletions, or missing 
      sections of DNA, on one of their two copies of chromosome 17. None of 
      the children’s parents had the section of DNA missing, which suggests 
      the anomaly is causative of the children’s physical and developmental 
      disabilities which included a combination of developmental delays 
      including speech delay, postnatal growth retardation, heart defects and 
      hand, foot and limb abnormalities.
    
    
      The researchers estimate the incidence of this genetic abnormality in 
      the general population to be approximately 1 in 115,000.
    
    
      Two of the genes in the deleted region were of particular interest to 
      researchers because of their potential role in the heart and limb 
      anomalies in the children. TBX2 and TBX4 are members of a 
      closely related gene family, the T-box genes, that is involved in 
      development. Mutations of TBX4 have been identified in 
      individuals with small patella syndrome, characteristic features of 
      which include delayed tissue formation of the pelvic bones and femur and 
      foot anomalies. Several other genetic disorders for which heart and limb 
      defects are characteristic features have been associated with disruption 
      of T-box genes, which led the researchers to suggest the newly reported 
      disorder is a similar “heart-hand” syndrome.
    
    
      “In a substantial proportion of children with mental retardation and 
      developmental delays, the genetic basis is unknown,” said Dr. Blake C. 
      Ballif, Director of Product Development and Research at Signature 
      Genomic Laboratories and lead author of the study. “Therefore, the 
      identification of a previously unknown genetic aberration sheds further 
      light on the genetic basis of human disease, in addition to providing an 
      answer for these children and their families.”
    
    
      Said Dr. Ballif, “In addition, this report represents a 
      collaborative academic effort by several otherwise competing diagnostic 
      laboratories to disseminate important clinical and molecular information 
      that significantly contributes to our understanding of the molecular 
      basis of human genetic disease.”